Patent application number | Description | Published |
20100178288 | USE OF APHANAMIXIS POLYSTACHA EXTRACTS OR FRACTIONS AGAINST 5-LIPOXYGENASE MEDIATED DISEASES - The invention discloses 5-lipoxygenase inhibitory product prepared from botanical sources. More specifically, the invention describes 5-lipoxygenase inhibitory extracts or bio-enriched extracts or fractions of | 07-15-2010 |
20100203117 | ANTI-ADIPOGENIC COMPOSITIONS CONTAINING PIPER BETLE AND DOLICHOS BIFLORUS - Herbal compositions are useful for inhibition, amelioration or prevention of adipogenesis mediated diseases such as obesity, lipid storage disease and hyperlipemia. The herbal compositions comprise biologically effective amounts of extracts or fractions from | 08-12-2010 |
20100209486 | Method of enhancing CoenzymeQ10 levels in mammals - The invention relates to a method of enriching the CoEnzyme Q | 08-19-2010 |
20100227828 | NEW SYNERGISTIC PHYTOCHEMICAL COMPOSITION FOR THE TREATMENT OF OBESITY - Synergistic anti-adipogenic and pro-lipolytic compositions for the prevention and amelioration of adipogenesis and lipolysis mediated diseases, comprising at least two extracts selected from enriched demethylated curcuminoids obtained from | 09-09-2010 |
20100292490 | A PROCESS FOR PRODUCING GAMMA MANGOSTIN - A process for the production of γ-mangostin comprising the steps of preparing O-methyl γ-mangostin preferably from plants, subjecting the pure or partially pure O-methylated γ-mangostin to demethylation reaction procedure followed by purification of the said demethylated product to obtain pure γ-mangostin. | 11-18-2010 |
20100298423 | NUTRACEUTICAL COMPOSITION FROM GARCINIA MANGOSTANA - Pharmaceutical, cosmetic, nutraceutical and dietary compositions derived from | 11-25-2010 |
20110212142 | CURCUMINOIDS AND ITS METABOLITES FOR THE APPLICATION IN OCULAR DISEASES - Aqueous ophthalmic compositions comprising natural or synthetic curcuminoids either alone or in combination, nonionic surfactant and co-solvent along with suitable ophthalmic excipients, effective in increasing the bioavailability of the active compounds when administered topically to the eye is disclosed herein. | 09-01-2011 |
20110229532 | PROCESS FOR NANOEMULSIFICATION OF CURCUMIN AND DERIVATIVES OF CURCUMIN - A process for nanomulsification of highly lipophillic polyphenols compounds using non-ionic surfactant and a non-ionic co-solvent with the help of sonar energy, to enhance the aqueous solubility is disclosed herein. | 09-22-2011 |
20110280951 | COMPOSITION FROM SPHAERANTHUS INDICUS AND GARCINIA MANGOSTANA FOR THE CONTROL OF METABOLIC SYNDROME - The invention relates pharmaceutical/dietary supplement/food ingredient(s) selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from | 11-17-2011 |
20120128808 | AGENTS FROM FICUS HISPIDA FOR THE AMELIORATION OF METABOLIC SYNDROME AND RELATED DISEASES - The invention discloses herbal ingredient(s) derived from | 05-24-2012 |
20120231095 | AGENTS DERIVED FROM HOLOPTELEA INTEGRIFOLIA AND THEIR COMPOSITIONS FOR THE CONTROL OF METABOLIC SYNDROME AND ASSOCIATED DISEASES - The invention discloses phytochemical agents derived from | 09-13-2012 |
20120301432 | NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS - The present disclosure describes | 11-29-2012 |
20130045183 | BOSWELLIA OIL, ITS FRACTIONS AND COMPOSITIONS FOR ENHANCING BRAIN FUNCTION - The present disclosure relates to non-acidic extracts or fractions selected from a | 02-21-2013 |
20130084348 | COMPOSITIONS COMPRISING NON-ACIDIC BOSWELLIA OIL FRACTION AS A BIO-ENHANCER FOR ENHANCING BIOAVAILABILITY OF BIOLOGICAL AGENTS - The invention relates to a non-acidic | 04-04-2013 |
20130136809 | 7-HYRDROXYFRULLANOLIDE ITS ANALOGS FOR PREVENTION CONTROL AND TREATMENT OF METABOLIC DISORDERS - The invention discloses biologically active ingredient(s) selected from 7-hydroxyfrullanolide, its analogs, the ex-tract(s) and fraction(s) standardized to 7-hydroxyfrullanolide or its analogs or both or mixtures thereof or their composition(s) for the prevention, control and treatment of one or more obesity, overweight, metabolic syndrome, diabetes and other metabolic disorders or for producing lean body mass in a warm blooded animal in need thereof. | 05-30-2013 |
20130189380 | SPHAERANTHUS INDICUS DERIVED INGREDIENTS AND THEIR COMPOSITIONS FOR ENHANCING PHYSICAL PERFORMANCE AND ENERGY LEVELS - The invention discloses herbal ingredients derived from | 07-25-2013 |
20130266563 | SUBSTITUTED 4-(SELENOPHEN-2(OR-3)-YLAMINO)PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF - Selenophene compounds of formula (I) are described herein. In the compounds of Formula (I), ring A is a 6-membered aromatic fused ring, optionally containing one, two or three nitrogen atoms; a 5-membered heteroaromatic fused ring; or a mono- or bicyclic saturated heterocyclic fused ring having at least one ring member selected from the group consisting of N, O, S, SO and SO | 10-10-2013 |
20150072012 | NOVEL HIGHLY BIOAVAILABLE, WATER SOLUBLE AND SUSTAINED RELEASE NANOFORMULATIONS HYDROPHOBIC PLANT DERIVED COMPOUNDS AND EXTRACTS - A highly bioavailable, water soluble, sustained release nanoformulation comprising a hydrophobic plant derived compound(s) in an emulsifier phase, and aqueous phase. The formulation provides sustained release of the hydrophobic plant derived compound(s) over a 24 hr time period. A process for preparation of the water soluble nanoformulation is described. | 03-12-2015 |